120 likes | 132 Views
According to the latest research report by IMARC Group, The global hemostats market size reached US$ 3.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.7 Billion by 2028, exhibiting a growth rate (CAGR) of 5.97% during 2023-2028.<br><br>More Info:- https://www.imarcgroup.com/hemostats-market
E N D
Global Hemostats Market Research and Forecast Report 2023-2028 Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2019 IMARC All Rights Reserved
Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Report Description and Highlights Report Description Global Hemostats Market Research Report: The latest report by IMARC, titled “Hemostats Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” the global hemostats market size reached US$ 3.3 Billion in 2022. Hemostats are utilized in different surgical procedures to stop bleeding. These agents are employed in the early phases for initial incisions and closing blood vessels until ligation. They help decrease wound healing and operative time, offering better management of anticoagulated patients and reducing the patient recovery period. At present, numerous surgical hemostatic agents are available in the market with varying costs, composition, application, adherence, immunogenicity and mechanism of action. Request Free Sample Report: https://www.imarcgroup.com/hemostats-market/requestsample
Report Description and Highlights Report Description Global Hemostats Market Trends: There is a significant rise in the demand for hemostats on account of the growing prevalence of fatal injuries, chronic disorders, cesarean deliveries and major organ surgeries. Hemostats help prevent blood loss during surgical procedures, especially for nonanatomic and sensitive structures, and among patients with hemostatic abnormalities. Apart from this, the rising geriatric population, along with the increasing number of minimally invasive (MI) surgeries, are strengthening the growth of the market. Furthermore, technological advancements and improving healthcare spending is driving the market growth. However, on account of the sudden outbreak of the coronavirus disease (COVID-19), healthcare providers are currently limiting the number of surgical procedures to prevent the spread of the pandemic, which is negatively impacting the market growth. Looking forward, the market value is projected to reach US$ 4.7 Billion by 2028, expanding at a CAGR of 5.97% during the forecast period (2023-2028). Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).
Report Description and Highlights Report Description Market Summary: Breakup by Product: • Thrombin Based • Combination Based • Oxidized Regenerated Cellulose Based • Gelatin Based • Collagen Based Breakup by Application: • Orthopedic Surgery • General Surgery • Neurological Surgery • Cardiovascular Surgery • Reconstructive Surgery • Gynecological Surgery • Others Breakup by Formulation: • Matrix and Gel Hemostats
Report Description and Highlights Report Description • Sheet and Pad Hemostats • Sponge Hemostats • Powder Hemostats Breakup by Region: • North America • United States • Canada • Asia Pacific • China • Japan • India • South Korea • Australia • Indonesia • Others • Europe • Germany • France • United Kingdom
Report Description and Highlights Report Description • Italy • Spain • Russia • Others • Latin America • Brazil • Mexico • Others • Middle East and Africa
Report Description and Highlights Report Description Competitive Landscape with Key Players: • • • • • • • • • • • Arch Therapeutics Inc. Baxter International Inc. B. Braun Melsungen Aktiengesell C. R. Bard Inc. GELITA MEDICAL GmbH Integra LifeSciences Corporation Johnson & Johnson Pfizer Inc. Stryker Corporation Teleflex Incorporated Z-Medica LLC. View Full Report with TOC & List of Figure: https://www.imarcgroup.com/hemostats-market
We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients
We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients
Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com